Tff Pharmaceuticals Inc (NASDAQ:TFFP)’s traded shares stood at 0.41 million during the latest session, with the company’s beta value hitting 1.36. At the last check today, the stock’s price was $2.10, to imply an increase of 1.94% or $0.04 in intraday trading. The TFFP share’s 52-week high remains $11.00, putting it -423.81% down since that peak but still an impressive 35.71% since price per share fell to its 52-week low of $1.35. The company has a valuation of $7.29M, with an average of 32420.0 shares in intraday trading volume over the past 10 days and average of 41.02K shares over the past 3 months.
Tff Pharmaceuticals Inc (NASDAQ:TFFP) trade information
After registering a 1.94% upside in the latest session, Tff Pharmaceuticals Inc (TFFP) has traded red over the past five days. The 5-day price performance for the stock is 1.45%, and -2.78% over 30 days. With these gigs, the year-to-date price performance is -70.09%. Short interest in Tff Pharmaceuticals Inc (NASDAQ:TFFP) saw shorts transact 0.13 million shares and set a 3.2 days time to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Tff Pharmaceuticals Inc (TFFP) estimates and forecasts
Looking at statistics comparing Tff Pharmaceuticals Inc share performance against respective industry, we note that the company has outperformed competitors. Tff Pharmaceuticals Inc (TFFP) shares are -28.12% down over the last 6 months, with its year-to-date growth rate higher than industry average at 63.88% against 17.50%. Revenue is forecast to grow 64.00% this quarter before jumping 63.70% for the next one. The rating firms project that company’s revenue will grow 56.70% compared to the previous financial year.
Revenue forecast for the current quarter as set by 1 analysts is 200k. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 200k.Earnings reports from the last fiscal year show that sales brought in 235k and 114k respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -14.90% before jumping 75.40% in the following quarter.
TFFP Dividends
Tff Pharmaceuticals Inc has its next earnings report out on 2024-Nov-12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Tff Pharmaceuticals Inc (NASDAQ:TFFP)’s Major holders
Tff Pharmaceuticals Inc insiders hold 3.31% of total outstanding shares, with institutional holders owning 22.48% of the shares at 23.25% float percentage. In total, 22.48% institutions holds shares in the company.
